J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4S):102104. doi: 10.1016/j.japh.2024.102104. Epub 2024 Apr 23.
Community-based pharmacists have historically lacked access to electronic medical records and clinical markers. Research was needed to assess the impact of obtaining clinical markers from a health information exchange (HIE) on pharmacist recommendations during a medication management encounter.
The objective of this project was to quantify and characterize clinical recommendations by pharmacists, resident pharmacists, or student pharmacists within an independent pharmacy setting that had access to patient information via an HIE.
Moose Pharmacy is one of few community pharmacies in North Carolina with access to a large health-system HIE.
This cohort study reviewed data over 4 months. Patients were identified for medication management based on filling eligible medications for atherosclerotic cardiovascular disease (ASCVD), hypertension, diabetes, dyslipidemia, or heart disease. Pharmacy personnel used the HIE to acquire laboratory test results. At the medication management appointment, the pharmacist collected blood pressure (BP), assessed smoking history, and medication or disease concerns. ASCVD risk score, statin therapy, A1c, and BP were assessed. Follow-up with the patient or provider was determined, if needed, and documented.
Collected records were reviewed to quantify the number and type of clinical recommendations made by the pharmacist, and their acceptance status by the prescriber. Descriptive analyses were used to analyze results.
Thirty-four encounters were included. Most participants had diabetes (n = 21, 62%) and hypertension (n = 31, 91%). Nearly one-third of encounters (n = 11, 32%) resulted in a pharmacist recommendation. Recommendations were for BP dose adjustments (n = 4, 36%), diabetes medication changes (n = 3, 27%), and statin initiations/escalations (n = 4, 36%). Four recommendations (36%) were accepted, with 1 requiring modifications from the provider; 3 recommendations (27%) were declined; and 3 recommendations (27%) were unanswered.
Access to progress notes and laboratory values using an HIE enhanced the pharmacist's ability to provide enhanced patient care recommendations during medication management consultations.
社区药剂师历史上无法访问电子病历和临床指标。需要研究通过健康信息交换(HIE)获取临床指标对药剂师在药物管理过程中提出建议的影响。
本项目的目的是量化和描述在独立药房环境中,药剂师、驻店药剂师或实习药剂师在使用 HIE 获得患者信息的情况下提出的临床建议,并对其进行特征描述。
Moose Pharmacy 是北卡罗来纳州少数几家能够访问大型医疗系统 HIE 的社区药房之一。
这项队列研究在四个月内对数据进行了回顾。根据患者是否正在服用治疗动脉粥样硬化性心血管疾病(ASCVD)、高血压、糖尿病、血脂异常或心脏病的合格药物,确定患者是否需要药物管理。药房工作人员使用 HIE 获取实验室检测结果。在药物管理预约时,药剂师收集血压(BP)、评估吸烟史以及药物或疾病相关问题。评估 ASCVD 风险评分、他汀类药物治疗、糖化血红蛋白和 BP,并确定是否需要进行患者或医生的随访,并进行记录。
回顾收集的记录,以量化药剂师提出的临床建议的数量和类型,以及这些建议被处方者接受的状态。使用描述性分析对结果进行分析。
共纳入 34 次就诊。大多数参与者患有糖尿病(n=21,62%)和高血压(n=31,91%)。近三分之一的就诊(n=11,32%)导致药剂师提出建议。建议包括 BP 剂量调整(n=4,36%)、糖尿病药物调整(n=3,27%)和他汀类药物起始/升级(n=4,36%)。四项建议(36%)被接受,其中一项需要来自医生的修改;三项建议(27%)被拒绝;三项建议(27%)未得到答复。
通过 HIE 获取进度记录和实验室值,增强了药剂师在药物管理咨询期间提供增强患者护理建议的能力。